Fortress Biotech Swings to Q3 Non-GAAP Loss, Revenue Drops
4:38PM ET 11/14/2022 MT NewswiresFortress Biotech (FBIO) reported Monday a Q3 non-GAAP loss of $0.08 per share, compared with earnings of $0.60 per share a year earlier. One analyst...
-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q3 Revenue $16.5M
4:09PM ET 11/14/2022 MT Newswires...
-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q3 Revenue $16.1M
4:08PM ET 11/14/2022 MT Newswires...
-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q2 Revenue $18.9M, vs. Street Est of $23.2M
4:33PM ET 8/11/2022 MT Newswires...
-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q2 Loss $-0.10, vs. Street Est of $-0.08
4:32PM ET 8/11/2022 MT Newswires...
--Ladenburg Thalmann Starts Fortress Biotech at Buy With $6 Price Target
7:03AM ET 8/04/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Fortress Biotech Names David Jin as CFO
8:43AM ET 7/22/2022 MT NewswiresFortress Biotech (FBIO) on Friday said it appointed David Jin as chief financial officer, effective Aug. 16. Jin will also continue serving as the...
B. Riley Securities Lowers Fortress Biotech's Price Target to $6 from $8, Keeps Buy Rating
9:54AM ET 7/14/2022 MT NewswiresFortress Biotech (FBIO) has an average rating of buy and price targets ranging from $3.50 to $10, according to analysts polled by Capital IQ. (MT Newswires...
Sector Update: Health Care Stocks Stumble Through Tuesday Trading
4:12PM ET 5/31/2022 MT NewswiresHealth care stocks continued to lose ground Tuesday afternoon, with the NYSE Health Care Index sinking 1.2% and the SPDR Health Care Select Sector ETF...